Literature DB >> 24419255

Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies?

Bongani M Mayosi1.   

Abstract

Cardiomyopathy classification has been subject to revisions for >60 years. The new MOGE(S) classification system, which incorporates information on structural and functional abnormalities, organ involvement, genetics, aetiology, and disease severity, is a step towards a globally accepted nomenclature, but needs to be applicable in all health-care systems around the world.

Entities:  

Mesh：

Year:  2014        PMID： 24419255     DOI： 10.1038/nrcardio.2013.219

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  10 in total

1.  Classification of cardiomyopathies: evolution or revolution?

Authors:  Perry M Elliott
Journal:  J Am Coll Cardiol       Date:  2013-11-18       Impact factor: 24.094

2.  The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.

Authors:  Eloisa Arbustini; Navneet Narula; G William Dec; K Srinath Reddy; Barry Greenberg; Sudhir Kushwaha; Thomas Marwick; Sean Pinney; Riccardo Bellazzi; Valentina Favalli; Christopher Kramer; Robert Roberts; William A Zoghbi; Robert Bonow; Luigi Tavazzi; Valentin Fuster; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-11-18       Impact factor: 24.094

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.

Authors: 
Journal:  Br Heart J       Date:  1980-12

Review 6.  Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa.

Authors:  Karen Sliwa; Bongani M Mayosi
Journal:  Heart       Date:  2013-05-16       Impact factor: 5.994

7.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

8.  Arrhythmias in idiopathic dilated cardiomyopathy. A preliminary study.

Authors:  S Chetty; A S Mitha
Journal:  S Afr Med J       Date:  1990-02-17

9.  Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.

Authors:  Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

10.  The contribution of South Africans to the subject of dilated cardiomyopathy - with reference to : cardiovascular collagenosis with parietal endocardial thrombosis : a clinicopathologic study of forty cases.

Authors:  D A Watkins; B M Mayosi
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167
  10 in total
  4 in total

1.  MOGE(S) nosology in low-to-middle-income countries.

Authors:  Eloisa Arbustini; Navneet Narula; G William Dec; K Srinath Reddy; Barry Greenberg; Sudhir Kushwaha; Thomas Marwick; Sean Pinney; Riccardo Bellazzi; Valentina Favalli; Christopher Kramer; Robert Roberts; William A Zoghbi; Robert Bonow; Luigi Tavazzi; Valentin Fuster; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

Review 2.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

Review 3.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies.

Authors:  Gehan Abd El-Rahman El-Zarea; Yasser Elsayed Mohamed Hassan; Ahmed Mohamed Ahmed Mahmoud
Journal:  Electron Physician       Date:  2016-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.